Product image of Nevirapina Teva Italia (Nevirapine) supplied by GNH India

Nevirapina Teva Italia

Active Ingredient:
Nevirapine
Origin:
EU

Nevirapina Teva Italia (Nevirapine)

Nevirapine, the active ingredient in Nevirapina Teva Italia, is a Non‑nucleoside reverse transcriptase inhibitor (NNRTI) presented as an oral tablet for oral use. It is indicated for the treatment of HIV‑1 infection, typically as part of combination antiretroviral therapy in adults and adolescents.

GNH India supplies Nevirapina Teva Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva Italia S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Nevirapine is used in the management of HIV‑1 infection and related therapeutic regimens.
  • HIV‑1 infection: reduces viral replication and helps achieve undetectable viral load.
  • Treatment‑naïve patients: forms part of first‑line combination antiretroviral therapy.
  • Prevention of mother‑to‑child transmission: used with other agents to lower transmission risk during pregnancy and delivery.

How It Works

  • Nevirapine binds to a non‑nucleoside site on the HIV‑1 reverse transcriptase enzyme, inducing a conformational change that impairs the enzyme’s ability to transcribe viral RNA into DNA. This inhibition blocks the synthesis of proviral DNA, preventing viral replication within host cells and reducing the overall viral load in the patient.

Side Effects

Nevirapine may cause a range of adverse reactions, from mild to severe, which should be monitored during therapy.

Common Side Effects

  • Rash: mild to moderate skin eruptions.
  • Headache: transient, often resolves with continued use.
  • Nausea: occasional gastrointestinal discomfort.
  • Fatigue: feeling of tiredness or weakness.
  • Diarrhea: loose stools, usually mild.

Serious or Rare Side Effects

  • Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention.
  • Hepatotoxicity: elevated liver enzymes or hepatitis.
  • Severe rash or hypersensitivity: may progress to systemic involvement.
  • Anemia: reduction in red blood cell count.
  • Immune reconstitution syndrome: worsening of opportunistic infections after immune recovery.

Precautions & Warnings

  • Patients should be evaluated for potential risks before initiating nevirapine therapy.
  • Baseline liver function tests: assess hepatic health prior to treatment.
  • HIV‑1 viral load monitoring: ensure therapeutic effectiveness.
  • Pregnancy considerations: discuss risks and benefits with a healthcare provider.
  • Concomitant medications: review for possible interactions.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Nevirapine can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid)

  • Rifampicin: reduces nevirapine levels, compromising efficacy.
  • Certain protease inhibitors (e.g., ritonavir): may increase toxicity risk.
  • St. John’s wort: induces metabolism, lowering drug exposure.

Moderate Interactions (Monitor Closely)

  • Warfarin: may alter anticoagulant effect, requiring INR monitoring.
  • Oral contraceptives: reduced effectiveness, consider alternative contraception.
  • Efavirenz: combined use may increase hepatic toxicity risk.

Frequently Asked Questions

Nevirapina Teva Italia contains nevirapine, an NNRTI indicated for the treatment of HIV‑1 infection. It is used as part of combination antiretroviral therapy in treatment‑naïve patients and may also be employed in regimens aimed at preventing mother‑to‑child transmission of HIV.

Nevirapine binds to a non‑nucleoside site on the HIV‑1 reverse transcriptase enzyme, causing a conformational change that blocks the enzyme’s ability to convert viral RNA into DNA. This inhibition prevents the virus from replicating within host cells, thereby reducing viral load.

The specific dosage of Nevirapina Teva Italia is determined by the prescribing clinician based on individual patient factors, including treatment history, weight, and co‑administered medications. Patients should follow the dosing regimen provided by their healthcare professional.

Nevirapine’s safety in pregnancy and lactation is not fully established. Healthcare providers weigh potential benefits against risks, especially considering the importance of controlling maternal HIV infection. Breastfeeding while on nevirapine is generally discouraged unless the benefits outweigh the risks.

To request Nevirapina Teva Italia, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nevirapine belongs to the NNRTI class, differing from nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitors. Compared with other NNRTIs, nevirapine has a longer half‑life but carries a higher risk of skin and hepatic reactions, requiring careful monitoring.

Nevirapina Teva Italia should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight and extreme temperatures to maintain product stability.

Nevirapina Teva Italia is taken orally, usually with food to improve tolerability. The tablets are swallowed whole with a glass of water. Patients should adhere to the dosing schedule prescribed by their clinician.

Serious adverse events linked to nevirapine include severe skin reactions such as Stevens‑Johnson syndrome, toxic epidermal necrolysis, and hepatotoxicity that may progress to liver failure. Prompt medical evaluation is essential if symptoms like rash, jaundice or fever develop.

Nevirapine is contraindicated in patients with a history of hypersensitivity to the drug, severe hepatic impairment, or those who have experienced serious skin reactions to nevirapine or other NNRTIs. It should also be avoided in individuals with active hepatitis B or C without close monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nevirapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT